Literature DB >> 28754761

Directly observed therapy for clozapine with concomitant methadone prescription: a method for improving adherence and outcome.

Nicholas Tze Ping Pang1, Mohd Fadzli Mohamad Isa2, Vikram Suarn Singh3, Ruziana Masiran4.   

Abstract

A young male presented with many years of delusions and hallucinations, with concurrent heroin use and subsequent amphetamine uses. There were no depressive or manic symptoms and psychotic symptoms prior to the amphetamine use. After the trials of two atypical antipsychotics and later clozapine due to treatment resistance, adherence and functionality were poor and there was still persistent drug use. As a result, a long acting injectable adjunct was commenced, but only minimal effects were observed. However after initiation of directly observed treatment of clozapine with methadone, there has been functional and clinical response and drug use has ceased. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  drug misuse (including addiction); drugs misuse (including addiction); psychiatry (drugs and medicines); schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28754761      PMCID: PMC5624023          DOI: 10.1136/bcr-2017-221048

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  How much of China's success in tuberculosis control is really due to DOTS?

Authors:  S Bertel Squire; Shenglan Tang
Journal:  Lancet       Date:  2004 Jul 31-Aug 6       Impact factor: 79.321

Review 2.  The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta analysis.

Authors:  Saeed Farooq; Matthew Large; Olav Nielssen; Waquas Waheed
Journal:  Schizophr Res       Date:  2009-02-23       Impact factor: 4.939

Review 3.  Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.

Authors:  Jonathan P Lacro; Laura B Dunn; Christian R Dolder; Susan G Leckband; Dilip V Jeste
Journal:  J Clin Psychiatry       Date:  2002-10       Impact factor: 4.384

4.  Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.

Authors:  R D Moore; C P Chaulk; R Griffiths; S Cavalcante; R E Chaisson
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

5.  Compliance in psychoses.

Authors:  O Kampman; K Lehtinen
Journal:  Acta Psychiatr Scand       Date:  1999-09       Impact factor: 6.392

6.  Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS).

Authors:  Saeed Farooq; Zahid Nazar; Muhammad Irfan; Javed Akhter; Ejaz Gul; Uma Irfan; Farooq Naeem
Journal:  Br J Psychiatry       Date:  2011-12       Impact factor: 9.319

7.  Community outreach for untreated schizophrenia in rural India: a follow-up study of symptoms, disability, family burden and costs.

Authors:  R Srinivasa Murthy; K V Kishore Kumar; D Chisholm; T Thomas; K Sekar; C R Chandrashekari
Journal:  Psychol Med       Date:  2005-03       Impact factor: 7.723

8.  Treating schizophrenia with DOTS in developing countries: one size does not fit all.

Authors:  Renato Souza; Silvia Yasuda; Susanna Cristofani
Journal:  PLoS Med       Date:  2007-09       Impact factor: 11.069

9.  Guardianship networks for rural psychiatric patients. A non-professional support system in Jinshan County, Shanghai.

Authors:  F Qiu; S Lu
Journal:  Br J Psychiatry Suppl       Date:  1994-08

Review 10.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

  10 in total
  1 in total

1.  Risk factors for readmission among a cohort of psychiatric inpatients in Lilongwe, Malawi.

Authors:  Brian S Barnett; Veronica Kusunzi; Lucy Magola; Christina P C Borba; Michael Udedi; Kazione Kulisewa; Mina C Hosseinipour
Journal:  Int J Psychiatry Clin Pract       Date:  2019-12-04       Impact factor: 1.812

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.